Eosinophilic esophagitis (EE) is the eosinophilic involvement of esophagus that occurs nowhere else in intestinal system. Liver transplantation is the universally accepted treatment option in end-stage acute and chronic liver disease and by liver diseases resistant to treatment. Moreover, success of the transplantation depends on immunosuppressive agents like tacrolimus and cyclosporin A. Because of the breakdown of the intestinal barrier due to tacrolimus, cellular energy production in the mucosa is blocked and it becomes sensitive to antigens. Thus, it causes eosinophilic diseases. Twenty two years old male patient with liver transplantation presented with retching and vomiting. This patient was diagnosed with Wilson\'s disease and transplanted at the age of 16 and during his 6 years follow-up he only used tacrolimus as an immunosuppressive agents. Endoscopy revealed rings, histopathology showed >15 eosinophils for each area under bigger magnification and the patient was diagnosed with eosinophilic esophagitis. Patient was administered systemic steroids and topical steroids respectively. After treatment the complaints resolved and patient was discharged. During an approximately 2 years of follow-up there was no recurrence. We aimed to present this case of a 22 years old male with liver transplantation currently under outpatient follow-up presenting with eosinophilic esophagitis and responded very well to steroid treatment.